These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15154871)

  • 1. Filtration leukocytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate.
    Kempe K; Tsuda H; Yang K; Yamaji K; Kanai Y; Hashimoto H
    Ther Apher Dial; 2004 Jun; 8(3):197-205. PubMed ID: 15154871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the clinical effect of large volume leukocytapheresis on methotrexate-resistant rheumatoid arthritis.
    Onuma S; Yamaji K; Kempe K; Ogasawara M; Ogawa T; Yang K; Kanai M; Tsuda H; Takasaki Y
    Ther Apher Dial; 2006 Oct; 10(5):404-11. PubMed ID: 17096694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filtration leukocytapheresis therapy in rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.
    Hidaka T; Suzuki K; Matsuki Y; Takamizawa-Matsumoto M; Kataharada K; Ishizuka T; Kawakami M; Nakamura H
    Arthritis Rheum; 1999 Mar; 42(3):431-7. PubMed ID: 10088764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adsorptive granulocyte/monocyte apheresis for the treatment of refractory rheumatoid arthritis: an open pilot multicentre trial.
    Sanmartí R; Marsal S; Valverde J; Casado E; Lafuente R; Kashiwagi N; Rodriguez-Cros JR; Erra A; Reina D; Gratacós J
    Rheumatology (Oxford); 2005 Sep; 44(9):1140-4. PubMed ID: 15927997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
    Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Prosorba column apheresis in patients with chronic refractory rheumatoid arthritis.
    Roth S
    J Rheumatol; 2004 Nov; 31(11):2131-5. PubMed ID: 15517623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab therapy in established rheumatoid arthritis: an observational study.
    Voulgari PV; Alamanos Y; Nikas SN; Bougias DV; Temekonidis TI; Drosos AA
    Am J Med; 2005 May; 118(5):515-20. PubMed ID: 15866254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis].
    Gubar' EE; Bochkova AG; Bunchuk NV
    Ter Arkh; 2008; 80(5):25-30. PubMed ID: 18590110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis.
    Cohen SB; Cheng TT; Chindalore V; Damjanov N; Burgos-Vargas R; Delora P; Zimany K; Travers H; Caulfield JP
    Arthritis Rheum; 2009 Feb; 60(2):335-44. PubMed ID: 19180516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
    Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L
    J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate.
    Lu LJ; Bao CD; Dai M; Teng JL; Fan W; Du F; Yang NP; Zhao YH; Chen ZW; Xu JH; He PG; Wu HX; Tao Y; Zhang MJ; Han XH; Li XF; Gu JR; Li JH; Yu H
    Arthritis Rheum; 2009 Jul; 61(7):979-87. PubMed ID: 19565542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
    Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and immunological effects of leukapheresis therapy using cotton-wool filter for patients with rheumatoid arthritis].
    Takeda M
    Ryumachi; 1996 Jun; 36(3):493-502. PubMed ID: 8779786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial.
    Fleischmann RM; Cohen SB; Moreland LW; Schiff M; Mease PJ; Smith DB; Keenan G; Kremer JM;
    Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis.
    Ueki Y; Nakamura H; Kanamoto Y; Miyazaki M; Yano M; Matsumoto K; Miyake S; Tominaga T; Tominaga M; Yamasaki S; Eguchi K
    Ther Apher; 2001 Dec; 5(6):455-61. PubMed ID: 11800080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations between symptoms as assessed in traditional chinese medicine (TCM) and ACR20 efficacy response: a comparison study in 396 patients with rheumatoid arthritis treated with TCM or Western medicine.
    He Y; Lu A; Zha Y; Yan X; Song Y; Zeng S; Liu W; Zhu W; Su L; Feng X; Qian X; Lu C
    J Clin Rheumatol; 2007 Dec; 13(6):317-21. PubMed ID: 18176139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
    Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
    Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase 2 dose-finding study of PEGylated recombinant methionyl human soluble tumor necrosis factor type I in patients with rheumatoid arthritis.
    Furst DE; Fleischmann R; Kopp E; Schiff M; Edwards C; Solinger A; Macri M;
    J Rheumatol; 2005 Dec; 32(12):2303-10. PubMed ID: 16331754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.